Extension 4: Fourth Temporary Rule
For Extension 4: Fourth Temporary Rule, published is 12/31/2025; federal register citation is 90 FR 61301; document number is 2025-24123; effective period as stated is This rule is effective January 1, 2026 through December 31, 2026; flexibility extended through is December 31, 2026, verified against its source on 2026-08-31.
- Temporary rule
- Extension 4: Fourth Temporary Rule our reading
- Published
- 12/31/2025 verified
- Federal Register citation
- 90 FR 61301 verified
- Document number
- 2025-24123 verified
- Effective period as stated
- This rule is effective January 1, 2026 through December 31, 2026. verified
- Flexibility extended through
- December 31, 2026 verified
- Expiry date this rule replaced
- December 31, 2025 verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
What the source says
A Rule by the Drug Enforcement Administration and the Health and Human Services Department on 12/31/2025 Published Document: 2025-24123 (90 FR 61301)
— federalregister.gov, retrieved 2026-08-31
Where each value comes from
This source states these in separate places, so each value is shown with the passage that states it.
Effective period as stated
DATES: This rule is effective January 1, 2026 through December 31, 2026.
Flexibility extended through
The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.
Expiry date this rule replaced
Paragraph (a) is amended to state that the authorization granted in paragraph (b) expires at the end of December 31, 2026, instead of December 31, 2025.
— all from federalregister.gov, retrieved 2026-08-31
Source
- federalregister.govhttps://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled